Search research articles
Contact Us
Filters
Showing results (1-10 of 278) with videos related to
Page
of 28
Sort By:
The Israel Medical Association Journal : IMAJ
|
October 14, 2024
Novelties in the Hyperferritinemic Syndrome: New Insights from Systemic Sclerosis
Piero Ruscitti
Expert Review of Clinical Immunology
|
October 9, 2018
Pathogenesis of adult onset still's disease: current understanding and new insights
Piero Ruscitti, Roberto Giacomelli
Reviews on Recent Clinical Trials
|
August 8, 2018
Cardiometabolic Comorbidities in Autoimmune Rheumatic Diseases: From Pathogenesis to Treatment
Francesco Ursini, Piero Ruscitti
The Israel Medical Association Journal : IMAJ
|
November 25, 2020
Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives
Piero Ruscitti, Roberto Giacomelli
Frontiers in Medicine
|
February 21, 2022
Editorial: Comorbidities in Psoriatic Arthritis and Their Impact on Therapeutic Strategies
Ilenia Pantano, Piero Ruscitti
Rheumatology (Oxford, England)
|
July 23, 2025
The increasing clinical relevance of systemic autoinflammatory diseases
Ilenia Di Cola, Piero Ruscitti
Expert Opinion on Biological Therapy
|
January 29, 2024
The latest advances in the use of biological DMARDs to treat Still's disease
Ilenia Di Cola, Piero Ruscitti
Journal of Autoimmunity
|
August 6, 2018
A comprehensive review on adult onset Still's disease
Roberto Giacomelli, Piero Ruscitti, Yehuda Shoenfeld
British Journal of Haematology
|
November 8, 2014
Stem cell therapies for systemic sclerosis
Paola Cipriani, Piero Ruscitti, Roberto Giacomelli
Journal of Psychosomatic Research
|
March 23, 2023
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
Piero Ruscitti, Francesco Ursini, Yehuda Shoenfeld
Page
of 28
Search research articles
Search
Showing results (1-10 of 278) with videos related to
Sort By:
Page
of 28
The Israel Medical Association Journal : IMAJ
|
October 14, 2024
Novelties in the Hyperferritinemic Syndrome: New Insights from Systemic Sclerosis
Piero Ruscitti
Expert Review of Clinical Immunology
|
October 9, 2018
Pathogenesis of adult onset still's disease: current understanding and new insights
Piero Ruscitti, Roberto Giacomelli
Reviews on Recent Clinical Trials
|
August 8, 2018
Cardiometabolic Comorbidities in Autoimmune Rheumatic Diseases: From Pathogenesis to Treatment
Francesco Ursini, Piero Ruscitti
The Israel Medical Association Journal : IMAJ
|
November 25, 2020
Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives
Piero Ruscitti, Roberto Giacomelli
Frontiers in Medicine
|
February 21, 2022
Editorial: Comorbidities in Psoriatic Arthritis and Their Impact on Therapeutic Strategies
Ilenia Pantano, Piero Ruscitti
Rheumatology (Oxford, England)
|
July 23, 2025
The increasing clinical relevance of systemic autoinflammatory diseases
Ilenia Di Cola, Piero Ruscitti
Expert Opinion on Biological Therapy
|
January 29, 2024
The latest advances in the use of biological DMARDs to treat Still's disease
Ilenia Di Cola, Piero Ruscitti
Journal of Autoimmunity
|
August 6, 2018
A comprehensive review on adult onset Still's disease
Roberto Giacomelli, Piero Ruscitti, Yehuda Shoenfeld
British Journal of Haematology
|
November 8, 2014
Stem cell therapies for systemic sclerosis
Paola Cipriani, Piero Ruscitti, Roberto Giacomelli
Journal of Psychosomatic Research
|
March 23, 2023
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
Piero Ruscitti, Francesco Ursini, Yehuda Shoenfeld
Page
of 28